Neurochemical effects in vitro and in vivo of the antidepressant Ro 11-1163, a specific and short-acting MAO-A inhibitor.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology*; D044482:Benzeneacetamides; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007276:Injections, Intraventricular; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010078:Oxazines / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D023303:Oxazolidinones; D051381:Rats; D013997:Time Factors
D000928:Antidepressive Agents; D001549:Benzamides; D044482:Benzeneacetamides; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010078:Oxazines; D010080:Oxazoles; D023303:Oxazolidinones; C006919:caroxazone; D020912:Moclobemide; C026234:cimoxatone